Menu Search
Equities

Tianda Pharmaceuticals Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
455:HKG.HZ

Tianda Pharmaceuticals Ltd

Actions
  • Price (HKD)0.108
  • Today's Change0.00 / 0.00%
  • Shares traded100.00k
  • 1 Year change-41.62%
  • Beta-0.0465
Data delayed at least 15 minutes, as of Feb 12 2026 07:19 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Tianda Pharmaceuticals Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Pharmaceuticals and Medical Technologies Business segment is mainly engaged in the sale of pharmaceutical, biotechnology and healthcare products. The segment is also engaged in the provision of contract development and manufacturing organisation (CDMO) services. The Chinese Medicine Business segment is mainly engaged in the sale of Chinese medicine products. The Medical and Healthcare Services segment is mainly engaged in the sale of healthcare and Chinese medicine products. The segment is also engaged in the provision of Chinese medical services. Additionally, the Company is engaged in the sales of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicine.

  • Revenue in HKD (TTM)310.50m
  • Net income in HKD-67.37m
  • Incorporated--
  • Employees624.00
  • Location
    Tianda Pharmaceuticals LtdSuites2405-2410, 24th Floor, CITIC TowerNo.1 Tim Mei AvenueCentral Hong KongHKG
  • Phone+852 25453313
  • Fax+852 25416558
  • Websitehttps://www.tiandapharma.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.